Home > Journals > Minerva Medica > Past Issues > Minerva Medica 2016 June;107(3 Suppl 1) > Minerva Medica 2016 June;107(3 Suppl 1):12-9

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions
Cite this article as

 

REVIEWS  PNEUMOLAB PROCEEDINGS 10 Freefree

Minerva Medica 2016 June;107(3 Suppl 1):12-9

Copyright © 2016 EDIZIONI MINERVA MEDICA

language: English

The immunobiological and clinical role of vitamin D in obstructive lung diseases

Paolo SOLIDORO 1, Michela BELLOCCHIA 1, Fabrizio FACCHINI 2

1 Pulmonary Medicine Unit, Department of Cardiovascular and Thoracic Surgery, Città della Salute e della Scienza University Hospital, University of Turin, Turin, Italy; 2 Pulmonary Medicine Unit, Vittorio Veneto Hospital, Treviso, Italy


PDF


Vitamin D is a fat-soluble vitamin, which is obtained by conversion of 7-dehydrocholesterol in the skin by UV ray and by diet. Its role on bone mineralization has been known for over two hundred years, while its non-skeletal effects have been acknowledged only in the last few years. The discovery of important vitamin D properties on the innate and adaptive immune system created a lot of interest in a potential role of vitamin D on diseases characterized by heightened inflammation and oxidative response, and impaired antimicrobial response, such as asthma and chronic obstructive pulmonary disease (COPD). Recent studies have demonstrated that vitamin D and its deficiency have a number of biological effects which are potentially important in altering the pathogenesis and severity of both asthma and COPD. Vitamin D may improve lung function and response to steroids therapy, reduce airway remodeling and disease exacerbations. The aim of this study is to review the role of Vitamin D in asthma and COPD.

top of page